These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8348968)
1. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968 [TBL] [Abstract][Full Text] [Related]
2. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line. Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779 [TBL] [Abstract][Full Text] [Related]
3. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
4. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9). Rabizadeh E; Shaklai M; Eisenbach L; Nudelman A; Rephaeli A Isr J Med Sci; 1996 Dec; 32(12):1186-91. PubMed ID: 9007151 [TBL] [Abstract][Full Text] [Related]
5. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880 [TBL] [Abstract][Full Text] [Related]
6. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis. Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791 [TBL] [Abstract][Full Text] [Related]
7. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells. Chen Z; Wang W; Pan J; Chen L; Xue Y Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538 [TBL] [Abstract][Full Text] [Related]
8. Novel anticancer prodrugs of butyric acid. 2. Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095 [TBL] [Abstract][Full Text] [Related]
9. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis. Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141 [TBL] [Abstract][Full Text] [Related]
10. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Canaparo R; Briatore F; Barrera G; Gasco MR; Bernengo MG; Eandi M; Zara GP Anticancer Drugs; 2004 Jun; 15(5):525-36. PubMed ID: 15166628 [TBL] [Abstract][Full Text] [Related]
11. [Low-dose recombinant human tumor necrosis-alpha in HL-60 leukemic cell line: effect on induced differentiation and regulating expression of c-myc, c-fos proto-oncogenes]. Yuan YC; Shen SY Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):666-9, 708-9. PubMed ID: 7866900 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine. Schwartz EL; Chamberlin H; Brechbühl AB Biochem Pharmacol; 1990 Dec; 40(11):2449-55. PubMed ID: 1702632 [TBL] [Abstract][Full Text] [Related]
13. c-myc protein expression during cell cycle phases in differentiating HL-60 cells. Kumakura S; Ishikura H; Tsumura H; Hayashi H; Endo J; Tsunematsu T Leuk Lymphoma; 1994 Jun; 14(1-2):171-80. PubMed ID: 7920226 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. Zeng C; Yu X; Lai J; Yang L; Chen S; Li Y J Hematol Oncol; 2015 Nov; 8():126. PubMed ID: 26545364 [TBL] [Abstract][Full Text] [Related]
15. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media. Bacon TA; Wickstrom E Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946 [TBL] [Abstract][Full Text] [Related]
16. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes. Mollinedo F; Gajate C; Tugores A; Flores I; Naranjo JR Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):137-44. PubMed ID: 8363564 [TBL] [Abstract][Full Text] [Related]
17. Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. Aviram A; Rephaeli A; Shaklai M; Nudelman A; Ben-Dror I; Maron L; Rabizadeh E J Cancer Res Clin Oncol; 1997; 123(5):267-71. PubMed ID: 9201249 [TBL] [Abstract][Full Text] [Related]
18. Lithium and hydrocortisone interactions on cell growth and gene expression in human promyelocytic leukemia (HL60). Knight SC; Harnish D; Scheid E; Koekebakker M; Barr RD Leuk Res; 1989; 13(4):289-96. PubMed ID: 2523989 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression. Rottleb C; Hall C; Bornkamm GW; Polack A Int J Cancer; 1996 Sep; 67(5):724-9. PubMed ID: 8782665 [TBL] [Abstract][Full Text] [Related]
20. Regulation of proto-oncogene and tumor necrosis factor gene expression by ethanol in HL-60 myeloid leukemia cells. Datta R; Sherman ML; Kufe DW Blood; 1990 Jul; 76(2):298-301. PubMed ID: 2196091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]